Toward a total cure for acute lymphoblastic leukemia.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Improved prognosis for older adolescents with acute lymphoblastic leukemia.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2011
   Trial
2. Interactions of Consanguinity and Number of Siblings with Childhood Acute Lymphoblastic Leukemia.BioMed research international · 2020
   Article
3. Improving treatment of children with acute lymphoblastic leukemia in developing countries through technology sharing, collaboration and partnerships.Expert review of hematology · 2014
   Review
4. Emotional/Behavioral problems in children with acute lymphoblastic leukemia: a case-control study.International journal of hematology-oncology and stem cell research · 2014
   Article
5. De novo engineering of a human cystathionine-γ-lyase for systemic (L)-Methionine depletion cancer therapy.ACS chemical biology · 2012
   Article
6. Preclinical activity of LBH589 alone or in combination with chemotherapy in a xenogeneic mouse model of human acute lymphoblastic leukemia.Leukemia · 2012
   Article
7. Gene expression signatures and ex vivo drug sensitivity profiles in children with acute lymphoblastic leukemia.Journal of applied genetics · 2012
   Article

Corrections and comments

• Comment on
  Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.2009
• Comment on
  Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.2009
• Comment on
  Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow.2009

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as